Insulet is trading 4.88% down at $129.00 in pre-market on October 6, 2026, with no clear company-specific catalyst reported. - Shares closed at $135.62 on October 5. - Major U.S. indices are higher, so broad-market weakness does not explain the decline. - Insulet’s latest investor announcement schedules third-quarter results for November 4. Recent coverage of revised debt terms does not link them to the pre-market move.